Fitch: Middle East Situation Continues to Pose Risks to Global Businesses
On July 4, Fitch Ratings released a report stating that despite the temporary memorandum of understanding signed between the U.S. and Iran on June 17, both sides continue to engage in retaliatory military strikes. The agreement remains fragile and Israel is not involved, which keeps the situation in the Middle East a risk for global businesses. In its updated 'negative scenario' analysis, Fitch pointed out that even if the currently set extreme scenarios (such as a 10% drop in the stock market, a widening of corporate bond spreads by 100-200 basis points, tightening monetary policy, and a noticeable slowdown in the global economy) do not fully materialize, they can still serve as a reference in the event of escalating conflict. In this scenario, the economic growth rates of the U.S. and the Eurozone would significantly decline. Fitch assessed 72 industry sub-sectors across six global regions, with most risk assessments remaining unchanged, while a few were adjusted up or down. Overall, Fitch believes that the 'tail risks' of the Middle East conflict persist, and if the situation escalates again, it will continue to exert pressure on the global corporate credit environment and financial markets.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Blackstone (BX.US) injects up to $1.5 billion, providing fresh ammunition for Pfizer (PFE.US) in the weight-loss drug race
Pfizer announced on Wednesday that it has reached an agreement with Blackstone to obtain up to $1.5 billions in funding to support the development of its experimental monthly obesity treatment drug.
Bernstein Downgrades Nvidia Rating and Target Price

Google (GOOGL.US) DeepMind launches AlphaGenome 2: Capable of decoding DNA cells with nearly double the mutation identification capacity
Google DeepMind has released its AI model AlphaGenome 2, which is trained on maps of over 100 millions of cells and has nearly double the ability of its predecessor in identifying gene expression variations.

The White House did not intervene in the decision-making of Nvidia's board of directors.
